MS
Mandeep Singh Bhamra
About Mandeep Singh Bhamra
Data last updated:
Mandeep Singh Bhamra is a Director at Ravenbhel Health Care Private Limited (since 2018) and Director at Salutem Pharmaceuticals Private Limited (since 2021). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹291 Cr; the largest is Ravenbhel Health Care Private Limited at ₹291 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ravenbhel Health Care Private Limited U24232JK2003PTC002286 | Director | 01 Jan 2018 | 2003 | ₹291 Cr (FY 2025) | Active |
 Salutem Pharmaceuticals Private Limited U24290JK2016PTC009772 | Director | 17 Jul 2021 | 2016 | ₹24.9 Lakh (FY 2025) | Active |
Board colleagues of Mandeep Singh Bhamra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Inam Ur Rehman | 01109816 | Ravenbhel Health Care Private Limited | Director |
| Sahil Mahajan | 00158373 | Ravenbhel Health Care Private Limited , Salutem Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mandeep Singh Bhamra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mandeep Singh Bhamra
Mandeep Singh Bhamra currently holds 2 directorships: Ravenbhel Health Care Private Limited (Director, since 01 Jan 2018, revenue ₹291 Cr (FY 2025)); Salutem Pharmaceuticals Private Limited (Director, since 17 Jul 2021, revenue ₹24.9 Lakh (FY 2025)).
Mandeep Singh Bhamra was first appointed on 01 Jan 2018 as Director at Ravenbhel Health Care Private Limited. The most recent appointment on record is 17 Jul 2021 at Salutem Pharmaceuticals Private Limited.
The 2 current companies of Mandeep Singh Bhamra that report revenue have a combined latest revenue of ₹291 Cr: Ravenbhel Health Care Private Limited ₹291 Cr (FY 2025); Salutem Pharmaceuticals Private Limited ₹24.9 Lakh (FY 2025).
The current boards of Mandeep Singh Bhamra's companies include Inam Ur Rehman (Ravenbhel Health Care Private Limited), Sahil Mahajan (Ravenbhel Health Care Private Limited).